cabozantinib + avelumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cabozantinib + avelumab, covering 2024-03-07 to 2024-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3) [Phase 2]